With GLP-1 medications already shifting what people buy, the piece asks what happens to the morning meal and the brands that sell it.
Recap by typeshit. Post by Food Manufacture on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
The drug behind Mounjaro and Zepbound slowed tumors in an early mouse study. Obesity is tied to higher breast cancer risk, especially after menopause, so the work is drawing interest.
The drug behind Mounjaro and Zepbound held back tumor growth in mouse studies. It's early animal work, but obesity is tied to higher breast cancer risk.
Loading…